NCT00146471View on ClinicalTrials.gov

Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

July 31, 2007

Study Completion Date

September 30, 2007

Conditions
Alcohol Withdrawal Syndrome
Interventions
DRUG

Levetiracetam

1500-2000 mg daily add-on or Placebo Diazepam as needed

DRUG

Placebo

1500-2000 mg daily add-on or Placebo Diazepam as needed

Trial Locations (5)

10117

Charité - Universitätsmedizin Berlin, Campus Charité Mitte, Klinik für Psychiatrie und Psychotherapie, Berlin

10559

Psychiatrische Klinik der Charité im St.-Hedwig Krankenhaus, Berlin

45136

Klinik für Psychiatrie und Suchtmedizin, Kliniken Essen Mitte, Essen

46414

Zentrum für Seelische Gesundheit, Rhede

06097

MLU Halle-Wittenberg, Halle

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT00146471 - Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrome | Biotech Hunter | Biotech Hunter